This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
« Back
Page 1 of 2

How to Invest in the Face of Deflation in the U.S. Economy

By Jason Orestes

All central banks attempt to avoid deflation like the plague. But why exactly is it so detrimental and how can it affect your investments?

11:25AM 04/06/15

AcelRx Pharmaceuticals: What Went Wrong and What's on the Horizon for the Struggling Biotech?

By Jason Orestes

AcelRx shareholders were burned yet again when the company announced new clinical trials were required for its flagship drug. What's to come for this struggling biotech company?

12:15PM 03/23/15

3 Reasons the U.S. Dollar Will Continue to Get Stronger

By Jason Orestes

The U.S. dollar has been one of the best performing currencies within the last year, but what has catalyzed this strength and will it continue?

10:36AM 02/17/15

What Is the Rationale Behind Owning a Negative-Yield Bond?

By Jason Orestes

A negative-yield bond literally means you are paying a government for the right to loan them money. What's the logic behind owning such a counterintuitive investment?

11:37AM 02/11/15

How the Death of Saudi King Abdullah Could Affect Oil Prices

By Jason Orestes

There should be no alterations in oil policy from Saudi Arabia, but be cognizant of any cabinet changes, specifically oil minister Al-Naimi.

08:52AM 01/23/15

Will the Second Time be a Charm for Biotech AcelRx After Their FDA Rejection?

By Jason Orestes

AcelRx Pharmaceuticals was hit with an FDA rejection and is due to resubmit their drug this quarter; should investors stay away or is there an opportunity to be had?

09:59AM 01/15/15

Super Smart Ways to Intelligently Invest in Communist Cuba

By Jason Orestes

Bullish on Cuba? A fund and some individual stocks you want to consider.

12:04PM 12/29/14

How Much GE, ExxonMobil and Other Big Firms Are Exposed to Russia

By Jason Orestes

Plunging oil prices and the skidding ruble have wreaked havoc on the Russian economy, creating major worries in global markets.

09:47AM 12/17/14

Who Are the Winners and Losers in a World of Plunging Oil Prices?

By Jason Orestes

The beneficiaries and those feeling the pain of declining oil prices aren't as straightforward as you think.

11:41AM 11/29/14

Does OPEC's Meeting Still Matter for Energy Stock Investors?

By Jason Orestes

Maybe only for the short-term price of oil.

08:55AM 11/26/14

« Back
Page 1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs